• Antihypertensive peptide IAPG

Antihypertensive peptide IAPG

Not For Human Use, Lab Use Only.

Cat.#: 308756

Special Price 75.90 USD

Availability: In Stock
- +

Add to cart to get an online quotation

Product Information

  • Product Name
    Antihypertensive peptide IAPG
  • Documents
  • Sequence Shortening
    IAPG
  • Sequence
    H-Ile-Ala-Pro-Gly-OH
  • Length (aa)
    4
  • Peptide Purity (HPLC)
    98.11%
  • Molecular Formula
    C16H28N4O5
  • Molecular Weight
    356.42
  • Source
    Synthetic
  • Form
    Powder
  • Description

    The peptide IAPG is a bioactive tetrapeptide with demonstrated angiotensin I-converting enzyme (ACE) inhibitory activity, originally identified from the microalga Spirulina platensis. It exhibits an IC50 value of 11.40 μM, indicating its potency as an ACE inhibitor. Structurally, IAPG consists of the amino acid sequence Isoleucine-Alanine-Proline-Glycine, which contributes to its interaction with the active site of ACE, a zinc metallopeptidase involved in the renin-angiotensin system.

    In a recombinant expression system using Pichia pastoris, IAPG was produced as part of a fusion polypeptide alongside other ACE-inhibitory peptides. Following purification and enzymatic digestion, IAPG was released and confirmed via reverse-phase HPLC. Its ACE-inhibitory mechanism involves competitive binding to the enzyme, reducing the conversion of angiotensin I to angiotensin II, a key vasoconstrictor. The peptide's stability and activity were further validated after pepsin hydrolysis, highlighting its potential as a functional bioactive peptide.

  • Storage Guidelines
    Normally, this peptide will be delivered in lyophilized form and should be stored in a freezer at or below -20 °C. For more details, please refer to the manual: Handling and Storage of Synthetic Peptides
  • References
    • Suetsuna K, Chen JR. Identification of antihypertensive peptides from peptic digest of two microalgae, Chlorella vulgaris and Spirulina platensis. Mar Biotechnol. 2001;3(4):305-9.
    • Tai HM, Li CC, Hung CY, Yin LJ. Production of functional peptides with inhibition ability against angiotensin I-Converting enzyme using P. pastoris expression system. J Food Drug Anal. 2018 Jul;26(3):1097-1104. doi: 10.1016/j.jfda.2018.02.001. Epub 2018 Feb 21. PMID: 29976402; PMCID: PMC9303040.
  • About TFA salt

    Trifluoroacetic acid (TFA) is a common counterion from the purification process using High-Performance Liquid Chromatography (HPLC). The presence of TFA can affect the peptide's net weight, appearance, and solubility.

    Impact on Net Weight: The TFA salt contributes to the total mass of the product. In most cases, the peptide content constitutes >80% of the total weight, with TFA accounting for the remainder.

    Solubility: TFA salts generally enhance the solubility of peptides in aqueous solutions.

    In Biological Assays: For most standard in vitro assays, the residual TFA levels do not cause interference. However, for highly sensitive cellular or biochemical studies, please be aware of its presence.

  • Molar Concentration Calculator

  • Dilution Calculator

  • Percent Concentration Calculator

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass
=
Concentration
×
Volume
×
Molecular Weight

Peptide Services: NovoPro's peptide synthesis services include standard chemical peptide synthesis, peptide modification, peptide libraries, and recombinant peptide expression.

Standard Peptide Synthesis: NovoPro offers quality peptides at the most competitive prices in the industry, starting at $3.20 per amino acid. NovoPro provides PepBox – Automatic Quote Tool for online price calculation.

Peptide Modifications: NovoPro offers a wide range of peptide modification services including isotope labeling (2H, 15N, and 13C), multiple disulfide bonds, multiple phosphorylations, KLH, BSA, ovalbumin, amidation, acetylation, biotin, FITC, etc.

Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"